|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1399 NEW YORK AVE, NW SUITE 725 |
Address2 | |
City | WASHINGTON |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 309071-12
|
||||||||
|
6. House ID# 384420000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Leslie Higgins, Director of Federal Government Relations |
Date | 01/21/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
S.1951/H.R. 3700 Fair Medicaid Drug Payment Act of 2007 regarding Medicaid reimbursement for generic drugs as related to average manufacturers price (AMP) and federal upper limits (FULs); H.R. 3140 Saving Our Community Pharmacies Act of 2007 regarding Medicaid reimbursement of generic drugs as related to AMP and FULs; S. 334 Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities;
S.980/H.R. 6353 Online Pharmacy Consumer Protection Act of 2007 regarding amendments to the Control Substances Act relating to the delivery of control substances over the internet; S.3101/H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 132 regarding incentives for electronic prescribing, Sec. 171 regarding prompt pay by PDPs and MA-PDs for prescriptions dispensed in Medicare Part D, Sec. 203 regarding reimbursement for generic drugs dispensed in the Medicaid program; S. 2408 "E-Meds Act of 2007 regarding amendments to the Social Security Act requiring physicians to utilize electronic prescribing for Medicare prescriptions; H.R. 2900 Food and Drug Amendments Act of 2007 Sec. 910 regarding pharmaceutical safety; H.R. 5839 Safeguarding Americas Pharmaceuticals Act of 2008 regarding amending the Food, Drug & Cosmetics Act to improve the safety of drugs; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation; S. 3001/ H.R. 5658 National Defense Authorization Act for Fiscal Year 2009 Sec. 702 regarding a freeze on current copays at retail pharmacies for medications dispensed in the TRICARE pharmacy program; MedGuides regarding improvements needed to the Medication Guide program no specific legislation; S. 1693 Wired for Healthcare Quality Act of 2007- Title IV Sec 401 Privacy and Security regarding changes in the definition of marketing under HIPAA and breach notification; H.R. 6357 PRO(TECH)T Act of 2008 - Title III regarding impact of privacy and security provisions on pharnacies, H.R. 6898 Health-e Information Technology Act of 2008 - Title IV regarding impact of privacy and security provisions on pharmacies.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
|
Debbie |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
S. 1276/H.R. 2747 Methamphetamine Production Prevention Act of 2007 regarding electronic logbooks and tracking systems for pseudoephedrine; H.R. 3610 Food and Drug Import Safety Act of 2007 Sec. 6 regarding country of origin labeling for drugs and devices; S. 2045 the Consumer Product Safety Commission Reform Act of 2007 Sec. 23 (e) regarding the implementation of new lead standards.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 6491 Organized Retail Crime Act of 2008 regarding amending title 18 of the U.S. Criminal Code to include organized retail crime and imposing requirements on "on-line" marketplaces to facilitate criminal investigations; S. 3434 Combating Organized Retail Crime Act of 2008 regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace;
H.R. 6713 the E-Fencing Enforcement Act of 2008, regarding amending the criminal code to impose duty on "on-line" marketplaces to retain contact information on "high volume" sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2914 Medicare IVIG Access Act of 2007 Sec. 4 regarding coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation this reporting period; H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008 Sec. 154 regarding a delay in the competitive acquisition program for DME.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Leslie |
Higgins |
|
|
|
Susie |
Schulte |
|
|
|
Heather |
Smith |
|
|
|
Debbie |
Garza |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |